Singapore could become the second country to legalise MRT but they are considering a new method that differs from the two currently legal in the UK.
Microbiotica has entered into a multi-year strategic collaboration with Genentech, a Roche company, to discover, develop, and commercialise biomarkers, targets, and medicines for inflammatory bowel disease.
The study of viral ecology is taking major leaps forward with the use of long-read sequencing and viral metagenomics. On this webinar we discuss how MinION technology is bringing scientists closer to high-throughput single-virus genomics from environmental samples.
A new study provides a unique look at a novel strategy — clinical trials in a dish — that bridges preclinical testing and clinical trials.
Some regulatory hurdles for makers of direct-to-consumer genetic health risk test have been lifted by the US Food and Drug Administration.
A security breach at DNA testing website MyHeritage have leaked the data of over 92 million users, the company said on Monday.
Yesterday’s news about the Oncotype DX test that could enable a lot of patients with breast cancer to safely forgo chemotherapy, is massive news for the breast cancer field. But it’s also big news for Genomic Health, the developer of the test.
A patient with metastatic breast cancer has made a dramatic recovery after receiving a personalised therapy using her own cells.
New research may explain the link between a high level of iron in the body and prostate cancer.
People’s medical and health history might become more than just a blueprint for doctor’s actions, now that blockchain start-up Nebula Genomics, and Hong Kong-based Longenesis are partnering up.
A 21-gene test performed on tumours could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study.
Researchers have devised a magnetic control system to make tiny DNA-based robots move on demand, and much faster than recently possible.